Here are 10 notes on the state of cardiology’s workforce and compensation in 2024, as reported by Becker’s:
Category: Featured
50% of US drug shortages last at least 2 years: ASHP
A survey by the American Society of Health-System Pharmacists found that 50% of active drug shortages in the U.S. persist for two or more years, the Pharmacy Times reported Nov. 1.
50% of US drug shortages last at least 2 years: ASHP
A survey by the American Society of Health-System Pharmacists found that 50% of active drug shortages in the U.S. persist for two or more years, the Pharmacy Times reported Nov. 1.
State flags Connecticut hospital for service cuts: 9 notes
Connecticut’s Office of Health Strategy has raised concerns with Vernon, Conn.-based Rockville General Hospital’s service cuts that “may be in violation” of state law, according to an Oct. 17 letter.
Prime Healthcare Texas hospital taps CEO
Josiah De La Garza has been named CEO of Dallas Regional Medical Center in Mesquite, Texas.
Semaglutide shows improvement in liver disease treatment in late stage trial
A Novo Nordisk Phase 3 trial found that 37% of adults with metabolic dysfunction-associated steatohepatitis who received once-weekly semaglutide 2.4 milligrams showed improvement in liver fibrosis without worsening steatohepatitis, a disease that cause…
California hospital property returns to community ownership
Watsonville (Calif.) Community Hospital’s property has been returned to the Pajaro Valley Health Care District.
Dr. Pronovost's wish for SEP-1 and other quality measurements
CMS releases a new rule for hospitals, healthcare organizations criticize the decision, the rule goes into effect anyway, and the cycle continues. Peter Pronovost, MD, PhD, wants to see this story be rewritten.
15 new ASCs in October
Here are 15 ASCs that were opened or announced in the last month, as reported by Becker’s:
2 drug companies to pay $49M in alleged inflation scheme
Two drug companies will pay a combined $49.1 million for their alleged involvement in schemes to inflate drug prices and limit competition in the generic pharmaceuticals market nationwide, the Connecticut Law Tribune reported Oct. 31.
